Evofem Biosciences (EVFM) Misses Q4 EPS by 14c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall St mixed as Middle East tensions eclipse tech strength
- L3Harris CEO steps down amid conduct review, shares drop
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
Evofem Biosciences Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update
March 4, 2021 4:00 PM ESTSAN DIEGO, March 4, 2021 /PRNewswire/ --Â Evofem Biosciences, Inc. (NASDAQ: EVFM), a commercial stage biopharmaceutical company, today reported financial results for the three- and twelve-month periods ended December 31, 2020.
"2020 was a year of execution for Evofem, marked by... More
